Area of research
Pathology and Forensic Medicine · Radiology, Nuclear Medicine and Imaging
Research interest
Research interests include Lymphoma Diagnosis and Treatment, Lung Cancer Treatments and Mutations, Medical Imaging Techniques and Applications, and CNS Lymphoma Diagnosis and Treatment.
Combined PET and ctDNA response as a predictor of POD24 for follicular lymphoma after first-line induction treatment
International Benchmark for Total Metabolic Tumor Volume Measurement in Baseline<sup>18</sup>F-FDG PET/CT of Lymphoma Patients: A Milestone Toward Clinical Implementation
Romidepsin Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone Versus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone in Patients With Previously Untreated Peripheral T-Cell Lymphoma: Final Analysis of the Ro-CHOP Trial
Classic Hodgkin Lymphoma: The LYSA pragmatic guidelines
Metabolic tumor volume predicts outcome in patients with advanced stage follicular lymphoma from the RELEVANCE trial
A tumor volume and performance status model to predict outcome before treatment in diffuse large B-cell lymphoma
Integrative analysis of a phase 2 trial combining lenalidomide with CHOP in angioimmunoblastic T-cell lymphoma
Total tumor burden in lymphoma – an evolving strong prognostic parameter
High total metabolic tumor volume at baseline predicts survival independent of response to therapy
MFN2-associated lipomatosis: Clinical spectrum and impact on adipose tissue
Prognostic model for high-tumor-burden follicular lymphoma integrating baseline and end-induction PET: a LYSA/FIL study
A phase II study of the oral JAK1/JAK2 inhibitor ruxolitinib in advanced relapsed/refractory Hodgkin lymphoma
Baseline Metabolic Tumor Volume Predicts Outcome in High–Tumor-Burden Follicular Lymphoma: A Pooled Analysis of Three Multicenter Studies